Articles by Tim Burroughs
STIC commits $840m to Korea's Iljin Materials
STIC Investments has led a KRW1 trillion ($840 million) investment in Iljin Materials, a Korean producer of electric foils used in lithium batteries and consumer electronics, to support the international expansion of its manufacturing footprint.
Vision Fund joins $300m round for China vaccine developer
SoftBank Vision Fund 2 and 5Y Capital have led a $300 million Series C extension for Suzhou Abogen Biosciences, a Chinese vaccine developer focused on mRNA products, including one for COVID-19.
Deal focus: Permira passes Tricor baton to Baring
Permira helped Tricor Group consolidate its position in Asian corporate services and upgrade its product offering. Under Baring Private Equity Asia’s ownership, the CEO wants to build a $10 billion company
Fund focus: A91 basks in India afterglow
Having increased its Fund II hard cap to $550 million in response to investor demand, the Indian manager is ready to address an Indian market that is increasingly digital, VC-exposed, and expensive
Deal focus: Serving biryani at scale
With biryani the dish of choice on India’s food delivery apps, Biryani By Kilo is looking to build out a standardized cloud kitchen model. It has $35 million in Series B funding to pursue this ambition
Australia deal-by-deal player Alceon sees investment uptick
Australia-based deal-by-deal investor Alceon Private Equity expects to complete four investments this year, having expanded its scope from consumer and retail to include healthcare, childcare, and IT services.
DCP leads $235m round for China's Datong Insurance
DCP Capital Partners has become the largest institutional shareholder in Datong Insurance Service, one of China’s leading insurance brokerages, after leading a RMB1.5 billion ($235 million) round.
PE investors wary of inflation in 2022 - AVCJ Forum
Inflation is top of mind for Asia-focused private equity investors as they assess the various uncertainties facing the industry in 2022, the AVCJ Private Equity & Venture Forum heard.
Legend hits first close on healthcare fund, launches TMT vehicle
Legend Capital has reached a first close of $177 million on its third US dollar-denominated China healthcare fund. It is one of five vehicles the GP has in the market, including its recently launched ninth flagship technology, media, and telecom (TMT)...
Japan space debris start-up Astroscale gets $109m Series F
Astroscale, a Japanese space tech start-up dedicated to cleaning up orbital debris, has raised $109 million in Series F funding from investors including London-listed Seraphim Space Investment Trust, Japan Growth Capital Investment, and Axa Life Insurance....
HESTA backs PEP-owned Australia software business
HESTA has acquired a A$120 million ($85 million) equity stake in Australian enterprise software and IT services provider Citadel, following its merger with medical practice software specialist Genie Solutions.
CVC exits Malaysia snacks business to Universal Robina
CVC Capital Partners has agreed to sell Malaysia-based snack foods producer Munchy Food Industries to Universal Robina Corporation (URC) – a branded consumer food and beverage business in the Philippines – for MYR1.93 billion ($454 million).
Secondaries supply-demand mismatch most extreme in Asia - AVCJ Forum
There is not enough capital in Asia to address the number of secondary opportunities – mirroring the situation globally – with investors claiming to have more transaction choices than ever before.
China biotech IPOs in Hong Kong to stay strong - AVCJ Forum
The frenzy for Chinese biotech developers listing in Hong Kong is expected to continue well into 2022, industry participants told the AVCJ Private Equity & Venture Forum.
Bain leads $69m Series C for Japan's Linc'well
Bain Capital has led a JPY8 billion ($69 million) Series C round for Linc’well, a Japan-based software-as-a-service (SaaS) provider that caters to medical institutions.
KKR backs Southeast Asia K-12 schools business
KKR has acquired a minority interest in the K-12 schools business of Taylor’s Education Group (TEG), one of the largest private education providers in Malaysia.
RedBird joins $840m round for India's Dream Sports
RedBird Capital Partners, a US investment firm that has extensive sport exposure and several months ago picked up a stake in an Indian Premier League (IPL) franchise, has co-led a $840 million round for local fantasy sports platform Dream Sports.
India's NoBroker joins unicorn club
General Atlantic, Tiger Global Management, and Moore Strategic Ventures have participated in a $210 million Series E round for Indian real estate marketplace NoBroker at a valuation of $1 billion.
Blume hits $105m first close on fourth India VC fund
Indian venture capital investor Blume Ventures has achieved a first close of $105 million on its fourth fund, exceeding the full amount raised in the previous vintage.
Australia's Five V sells GP stake
Australia-based Five V Capital has sold a 25% GP stake to Pinnacle Investment Management Group, a listed multi-affiliate platform investor that has interests in 14 Australian asset managers.
SPAC regime reflects HK's cautious approach to expansion - AVCJ Forum
The Hong Kong Stock Exchange (HKEx) is positioning its soon-to-launch special purpose acquisition company (SPAC) regime as part of efforts to broaden its appeal in terms of capital markets tools and geographies. At the same time, executives are wary of...
NetEase music spinout completes $449m Hong Kong IPO
Cloud Village, a music streaming business controlled by Chinese internet giant NetEase and backed by several private equity investors, has raised HK$3.5 billion ($449 million) through a Hong Kong IPO.
Deal focus: Orchestra delivers pizza to Seoul
Banolim has become Korea’s fourth-largest pizza delivery business largely on the back of savvy marketing and expansion in lower-tier cities. Orchestra Private Equity is supporting a rollout in Seoul
Deal focus: Icon retains its private equity appeal
EQT’s $1.67 billion acquisition of Icon Group underscores the recent trend in large-cap buyouts, as well as the long-term growth potential for cancer care specialists in Australia and the wider Asian region